If you have access to tirzepatide, it is the superior GLP-1 class option for combination with AOD 9604
Specific dietary adjustments can significantly reduce gas production: Limit carbonated beverages , which introduce additional gas into the digestive system Reduce intake of gas-producing foods such as beans, lentils, cruciferous vegetables (broccoli, cauliflower, cabbage), onions, and certain fruits Avoid fatty and fried foods , which further delay gastric emptying and may exacerbate symptoms Minimize artificial sweeteners (sorbitol, mannitol, xylitol), which can ferment in the gut Reduce dairy products if lactose intolerance is suspected Limit high-fiber foods temporarily during periods of significant symptoms Eating behaviors also play a crucial role
He points out that obesity is highly stigmatized and undertreated
The mechanistic interpretation offered most often is straightforward: recruiting the GIP pathway alongside GLP-1 appears to add to the metabolic effect rather than substitute for it
But if your insurance does not cover GLP-1 medications, Ro has fewer options since they do not offer the compounded alternative
PACKAGE LABEL MOUNJARO KwikPen 5 mg per dose (20 mg/2.4 mL [8.33 mg/mL]) NDC 0002-3455-11 Rx Only Mounjaro KwikPen (tirzepatide) injection 5 mg per dose 20 mg/2.4 mL (8.33 mg/mL) 1 Pen with 4 doses of 5 mg TURN THE DOSE KNOB ALL THE WAY UNTIL YOU SEE A
